Search research articles
Contact Us
Filters
Showing results (211-220 of 221) with videos related to
Page
of 23
Sort By:
Journal of Tropical Pediatrics
|
June 3, 2017
Efficacy of Oral Zinc Supplementation in Radiologically Confirmed Pneumonia: Secondary Analysis of a Randomized Controlled Trial
Narendra Kumar Bagri, Neha Bagri, Manisha Jana, et al.
The British Journal of Nutrition
|
April 8, 2010
Improvement in nutrition-related knowledge and behaviour of urban Asian Indian school children: findings from the 'Medical education for children/Adolescents for Realistic prevention of obesity and diabetes and for healthy aGeing' ( MARG) intervention study
Priyali Shah, Anoop Misra, Nidhi Gupta, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists
Bin Jiang, James J-W Duan, Sylwia Stachura, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2019
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
Zhonghui Lu, James J-W Duan, Haiyun Xiao, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists
James J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313
Michael G Yang, Myra Beaudoin-Bertrand, Zili Xiao, et al.
Journal of Medicinal Chemistry
|
April 19, 2017
Selective I<sub>Kur</sub> Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide
Prashantha Gunaga, John Lloyd, Somanadham Mummadi, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2017
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong, David S Weinstein, Zhonghui Lu, et al.
Journal of Medicinal Chemistry
|
January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Jun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 221) with videos related to
Sort By:
Page
of 23
Journal of Tropical Pediatrics
|
June 3, 2017
Efficacy of Oral Zinc Supplementation in Radiologically Confirmed Pneumonia: Secondary Analysis of a Randomized Controlled Trial
Narendra Kumar Bagri, Neha Bagri, Manisha Jana, et al.
The British Journal of Nutrition
|
April 8, 2010
Improvement in nutrition-related knowledge and behaviour of urban Asian Indian school children: findings from the 'Medical education for children/Adolescents for Realistic prevention of obesity and diabetes and for healthy aGeing' ( MARG) intervention study
Priyali Shah, Anoop Misra, Nidhi Gupta, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 3, 2020
Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists
Bin Jiang, James J-W Duan, Sylwia Stachura, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 2, 2019
Identification of potent, selective and orally bioavailable phenyl ((R)-3-phenylpyrrolidin-3-yl)sulfone analogues as RORγt inverse agonists
Zhonghui Lu, James J-W Duan, Haiyun Xiao, et al.
ACS Medicinal Chemistry Letters
|
March 21, 2019
Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yl)sulfones as Selective, Orally Active RORγt Inverse Agonists
James J-W Duan, Zhonghui Lu, Bin Jiang, et al.
Journal of Medicinal Chemistry
|
February 16, 2021
Tricyclic-Carbocyclic RORγt Inverse Agonists-Discovery of BMS-986313
Michael G Yang, Myra Beaudoin-Bertrand, Zili Xiao, et al.
Journal of Medicinal Chemistry
|
April 19, 2017
Selective I<sub>Kur</sub> Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide
Prashantha Gunaga, John Lloyd, Somanadham Mummadi, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 14, 2017
Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
Hua Gong, David S Weinstein, Zhonghui Lu, et al.
Journal of Medicinal Chemistry
|
January 10, 2018
Discovery of Potent and Orally Bioavailable Dihydropyrazole GPR40 Agonists
Jun Shi, Zhengxiang Gu, Elizabeth Anne Jurica, et al.
Page
of 23